A detailed history of Colonial Trust CO / Sc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Colonial Trust CO / Sc holds 10,034 shares of BMY stock, worth $545,046. This represents 0.07% of its overall portfolio holdings.

Number of Shares
10,034
Previous 10,169 1.33%
Holding current value
$545,046
Previous $551,000 24.5%
% of portfolio
0.07%
Previous 0.1%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $5,433 - $7,153
-135 Reduced 1.33%
10,034 $416,000
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $7,053 - $7,996
147 Added 1.47%
10,169 $551,000
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $15,755 - $18,801
-325 Reduced 3.14%
10,022 $514,000
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $17,367 - $19,419
-300 Reduced 2.82%
10,347 $600,000
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $47,209 - $52,418
-741 Reduced 6.51%
10,647 $680,000
Q1 2023

May 11, 2023

SELL
$65.71 - $74.53 $26,546 - $30,110
-404 Reduced 3.43%
11,388 $789,000
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $78,752 - $93,253
-1,150 Reduced 8.89%
11,792 $848,000
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $1,682 - $994,463
12,942 New
12,942 $920,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Colonial Trust CO / Sc Portfolio

Follow Colonial Trust CO / Sc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust CO / Sc, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust CO / Sc with notifications on news.